AbbVie - ABBV Short Interest Ratio & Short Volume

Short interest is the volume of AbbVie shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 14,040,000 shares of ABBV short. Learn More on AbbVie's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABBV shares currently have a short interest ratio of 2.0. Learn More on AbbVie's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AbbVie: Parallax Volatility Advisers L.P., Natixis, Point72 Middle East FZE, Jane Street Group LLC, Squarepoint Ops LLC, Laurion Capital Management LP, Millennium Management LLC, Maven Securities LTD, Centiva Capital LP, Jefferies Financial Group Inc., Point72 Hong Kong Ltd, Susquehanna International Group LLP, CSS LLC IL, Verition Fund Management LLC, Marshall Wace LLP, Natixis, Twin Tree Management LP, Wells Fargo & Company MN, Barclays PLC, Capital Fund Management S.A., JPMorgan Chase & Co., QVR LLC, Bank of America Corp DE, Capstone Investment Advisors LLC, Group One Trading L.P., IMC Chicago LLC, Citigroup Inc., InterOcean Capital Group LLC, UBS Group AG, SpiderRock Advisors LLC, Cutler Group LLC CA, SG Americas Securities LLC, Simplex Trading LLC, Gladius Capital Management LP, Wolverine Asset Management LLC, Concourse Financial Group Securities Inc., Steel Peak Wealth Management LLC, and XR Securities LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

AbbVie saw a increase in short interest in March. As of March 15th, there was short interest totaling 14,040,000 shares, an increase of 10.6% from the previous total of 12,700,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to AbbVie: Merck & Co., Inc. (0.77%), Eli Lilly and Company (0.96%), Pfizer Inc. (0.78%), Johnson & Johnson (0.48%), Bristol-Myers Squibb (1.00%), Zoetis Inc. (0.95%), AstraZeneca PLC (0.10%), Novo Nordisk A/S (0.08%), Novartis AG (0.32%), and Abbott Laboratories (0.74%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($3.66 billion), Occidental Petroleum Co. ($2.62 billion), Coinbase Global, Inc. ($2.38 billion), T. Rowe Price Group, Inc. ($2.13 billion), Verisk Analytics, Inc. ($2.08 billion), Snowflake Inc. ($1.95 billion), Paramount Global ($1.78 billion), Etsy, Inc. ($1.60 billion), Teck Resources Limited ($1.51 billion), and Voya Financial, Inc. ($1.49 billion). View all of the most shorted stocks.

Short selling ABBV is an investing strategy that aims to generate trading profit from AbbVie as its price is falling. ABBV shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for AbbVie occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ABBV, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABBV, twice per month. The most recent reporting period available is March, 15 2023.